Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Transthyretin Amyloidosis Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 ATTR-PN
1.2.3 ATTR-CM
1.3 Market by Application
1.3.1 Global Transthyretin Amyloidosis Treatment Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospital Pharmacies
1.3.3 Specialty Pharmacies
1.3.4 Retail Pharmacies
1.3.5 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Transthyretin Amyloidosis Treatment Market Perspective (2018-2033)
2.2 Transthyretin Amyloidosis Treatment Growth Trends by Region
2.2.1 Global Transthyretin Amyloidosis Treatment Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Transthyretin Amyloidosis Treatment Historic Market Size by Region (2018-2023)
2.2.3 Transthyretin Amyloidosis Treatment Forecasted Market Size by Region (2024-2033)
2.3 Transthyretin Amyloidosis Treatment Market Dynamics
2.3.1 Transthyretin Amyloidosis Treatment Industry Trends
2.3.2 Transthyretin Amyloidosis Treatment Market Drivers
2.3.3 Transthyretin Amyloidosis Treatment Market Challenges
2.3.4 Transthyretin Amyloidosis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Transthyretin Amyloidosis Treatment Players by Revenue
3.1.1 Global Top Transthyretin Amyloidosis Treatment Players by Revenue (2018-2023)
3.1.2 Global Transthyretin Amyloidosis Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Transthyretin Amyloidosis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Transthyretin Amyloidosis Treatment Revenue
3.4 Global Transthyretin Amyloidosis Treatment Market Concentration Ratio
3.4.1 Global Transthyretin Amyloidosis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Transthyretin Amyloidosis Treatment Revenue in 2022
3.5 Transthyretin Amyloidosis Treatment Key Players Head office and Area Served
3.6 Key Players Transthyretin Amyloidosis Treatment Product Solution and Service
3.7 Date of Enter into Transthyretin Amyloidosis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Transthyretin Amyloidosis Treatment Breakdown Data by Type
4.1 Global Transthyretin Amyloidosis Treatment Historic Market Size by Type (2018-2023)
4.2 Global Transthyretin Amyloidosis Treatment Forecasted Market Size by Type (2024-2033)
5 Transthyretin Amyloidosis Treatment Breakdown Data by Application
5.1 Global Transthyretin Amyloidosis Treatment Historic Market Size by Application (2018-2023)
5.2 Global Transthyretin Amyloidosis Treatment Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Transthyretin Amyloidosis Treatment Market Size (2018-2033)
6.2 North America Transthyretin Amyloidosis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Transthyretin Amyloidosis Treatment Market Size by Country (2018-2023)
6.4 North America Transthyretin Amyloidosis Treatment Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Transthyretin Amyloidosis Treatment Market Size (2018-2033)
7.2 Europe Transthyretin Amyloidosis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Transthyretin Amyloidosis Treatment Market Size by Country (2018-2023)
7.4 Europe Transthyretin Amyloidosis Treatment Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Transthyretin Amyloidosis Treatment Market Size (2018-2033)
8.2 Asia-Pacific Transthyretin Amyloidosis Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Transthyretin Amyloidosis Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Transthyretin Amyloidosis Treatment Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Transthyretin Amyloidosis Treatment Market Size (2018-2033)
9.2 Latin America Transthyretin Amyloidosis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Transthyretin Amyloidosis Treatment Market Size by Country (2018-2023)
9.4 Latin America Transthyretin Amyloidosis Treatment Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Transthyretin Amyloidosis Treatment Market Size (2018-2033)
10.2 Middle East & Africa Transthyretin Amyloidosis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Transthyretin Amyloidosis Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Transthyretin Amyloidosis Treatment Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer Inc.
11.1.1 Pfizer Inc. Company Detail
11.1.2 Pfizer Inc. Business Overview
11.1.3 Pfizer Inc. Transthyretin Amyloidosis Treatment Introduction
11.1.4 Pfizer Inc. Revenue in Transthyretin Amyloidosis Treatment Business (2018-2023)
11.1.5 Pfizer Inc. Recent Development
11.2 Johnson & Johnson Services, Inc.
11.2.1 Johnson & Johnson Services, Inc. Company Detail
11.2.2 Johnson & Johnson Services, Inc. Business Overview
11.2.3 Johnson & Johnson Services, Inc. Transthyretin Amyloidosis Treatment Introduction
11.2.4 Johnson & Johnson Services, Inc. Revenue in Transthyretin Amyloidosis Treatment Business (2018-2023)
11.2.5 Johnson & Johnson Services, Inc. Recent Development
11.3 Ionis Pharmaceuticals, Inc.
11.3.1 Ionis Pharmaceuticals, Inc. Company Detail
11.3.2 Ionis Pharmaceuticals, Inc. Business Overview
11.3.3 Ionis Pharmaceuticals, Inc. Transthyretin Amyloidosis Treatment Introduction
11.3.4 Ionis Pharmaceuticals, Inc. Revenue in Transthyretin Amyloidosis Treatment Business (2018-2023)
11.3.5 Ionis Pharmaceuticals, Inc. Recent Development
11.4 Alnylam Pharmaceuticals, Inc.
11.4.1 Alnylam Pharmaceuticals, Inc. Company Detail
11.4.2 Alnylam Pharmaceuticals, Inc. Business Overview
11.4.3 Alnylam Pharmaceuticals, Inc. Transthyretin Amyloidosis Treatment Introduction
11.4.4 Alnylam Pharmaceuticals, Inc. Revenue in Transthyretin Amyloidosis Treatment Business (2018-2023)
11.4.5 Alnylam Pharmaceuticals, Inc. Recent Development
11.5 BridgeBio Pharma, Inc.
11.5.1 BridgeBio Pharma, Inc. Company Detail
11.5.2 BridgeBio Pharma, Inc. Business Overview
11.5.3 BridgeBio Pharma, Inc. Transthyretin Amyloidosis Treatment Introduction
11.5.4 BridgeBio Pharma, Inc. Revenue in Transthyretin Amyloidosis Treatment Business (2018-2023)
11.5.5 BridgeBio Pharma, Inc. Recent Development
11.6 Bristol-Myers Squibb Company
11.6.1 Bristol-Myers Squibb Company Company Detail
11.6.2 Bristol-Myers Squibb Company Business Overview
11.6.3 Bristol-Myers Squibb Company Transthyretin Amyloidosis Treatment Introduction
11.6.4 Bristol-Myers Squibb Company Revenue in Transthyretin Amyloidosis Treatment Business (2018-2023)
11.6.5 Bristol-Myers Squibb Company Recent Development
11.7 Acrotech Biopharma
11.7.1 Acrotech Biopharma Company Detail
11.7.2 Acrotech Biopharma Business Overview
11.7.3 Acrotech Biopharma Transthyretin Amyloidosis Treatment Introduction
11.7.4 Acrotech Biopharma Revenue in Transthyretin Amyloidosis Treatment Business (2018-2023)
11.7.5 Acrotech Biopharma Recent Development
11.8 AstraZeneca
11.8.1 AstraZeneca Company Detail
11.8.2 AstraZeneca Business Overview
11.8.3 AstraZeneca Transthyretin Amyloidosis Treatment Introduction
11.8.4 AstraZeneca Revenue in Transthyretin Amyloidosis Treatment Business (2018-2023)
11.8.5 AstraZeneca Recent Development
11.9 Astellas Pharma, Inc.
11.9.1 Astellas Pharma, Inc. Company Detail
11.9.2 Astellas Pharma, Inc. Business Overview
11.9.3 Astellas Pharma, Inc. Transthyretin Amyloidosis Treatment Introduction
11.9.4 Astellas Pharma, Inc. Revenue in Transthyretin Amyloidosis Treatment Business (2018-2023)
11.9.5 Astellas Pharma, Inc. Recent Development
11.10 Prothena
11.10.1 Prothena Company Detail
11.10.2 Prothena Business Overview
11.10.3 Prothena Transthyretin Amyloidosis Treatment Introduction
11.10.4 Prothena Revenue in Transthyretin Amyloidosis Treatment Business (2018-2023)
11.10.5 Prothena Recent Development
11.11 SOM Biotech
11.11.1 SOM Biotech Company Detail
11.11.2 SOM Biotech Business Overview
11.11.3 SOM Biotech Transthyretin Amyloidosis Treatment Introduction
11.11.4 SOM Biotech Revenue in Transthyretin Amyloidosis Treatment Business (2018-2023)
11.11.5 SOM Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Transthyretin Amyloidosis Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of ATTR-PN
Table 3. Key Players of ATTR-CM
Table 4. Global Transthyretin Amyloidosis Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Transthyretin Amyloidosis Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Transthyretin Amyloidosis Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Transthyretin Amyloidosis Treatment Market Share by Region (2018-2023)
Table 8. Global Transthyretin Amyloidosis Treatment Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Transthyretin Amyloidosis Treatment Market Share by Region (2024-2033)
Table 10. Transthyretin Amyloidosis Treatment Market Trends
Table 11. Transthyretin Amyloidosis Treatment Market Drivers
Table 12. Transthyretin Amyloidosis Treatment Market Challenges
Table 13. Transthyretin Amyloidosis Treatment Market Restraints
Table 14. Global Transthyretin Amyloidosis Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Transthyretin Amyloidosis Treatment Market Share by Players (2018-2023)
Table 16. Global Top Transthyretin Amyloidosis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transthyretin Amyloidosis Treatment as of 2022)
Table 17. Ranking of Global Top Transthyretin Amyloidosis Treatment Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Transthyretin Amyloidosis Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Transthyretin Amyloidosis Treatment Product Solution and Service
Table 21. Date of Enter into Transthyretin Amyloidosis Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Transthyretin Amyloidosis Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Transthyretin Amyloidosis Treatment Revenue Market Share by Type (2018-2023)
Table 25. Global Transthyretin Amyloidosis Treatment Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Transthyretin Amyloidosis Treatment Revenue Market Share by Type (2024-2033)
Table 27. Global Transthyretin Amyloidosis Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Transthyretin Amyloidosis Treatment Revenue Market Share by Application (2018-2023)
Table 29. Global Transthyretin Amyloidosis Treatment Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Transthyretin Amyloidosis Treatment Revenue Market Share by Application (2024-2033)
Table 31. North America Transthyretin Amyloidosis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Transthyretin Amyloidosis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Transthyretin Amyloidosis Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Transthyretin Amyloidosis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Transthyretin Amyloidosis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Transthyretin Amyloidosis Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Transthyretin Amyloidosis Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Transthyretin Amyloidosis Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Transthyretin Amyloidosis Treatment Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Transthyretin Amyloidosis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Transthyretin Amyloidosis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Transthyretin Amyloidosis Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Transthyretin Amyloidosis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Transthyretin Amyloidosis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Transthyretin Amyloidosis Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 46. Pfizer Inc. Company Detail
Table 47. Pfizer Inc. Business Overview
Table 48. Pfizer Inc. Transthyretin Amyloidosis Treatment Product
Table 49. Pfizer Inc. Revenue in Transthyretin Amyloidosis Treatment Business (2018-2023) & (US$ Million)
Table 50. Pfizer Inc. Recent Development
Table 51. Johnson & Johnson Services, Inc. Company Detail
Table 52. Johnson & Johnson Services, Inc. Business Overview
Table 53. Johnson & Johnson Services, Inc. Transthyretin Amyloidosis Treatment Product
Table 54. Johnson & Johnson Services, Inc. Revenue in Transthyretin Amyloidosis Treatment Business (2018-2023) & (US$ Million)
Table 55. Johnson & Johnson Services, Inc. Recent Development
Table 56. Ionis Pharmaceuticals, Inc. Company Detail
Table 57. Ionis Pharmaceuticals, Inc. Business Overview
Table 58. Ionis Pharmaceuticals, Inc. Transthyretin Amyloidosis Treatment Product
Table 59. Ionis Pharmaceuticals, Inc. Revenue in Transthyretin Amyloidosis Treatment Business (2018-2023) & (US$ Million)
Table 60. Ionis Pharmaceuticals, Inc. Recent Development
Table 61. Alnylam Pharmaceuticals, Inc. Company Detail
Table 62. Alnylam Pharmaceuticals, Inc. Business Overview
Table 63. Alnylam Pharmaceuticals, Inc. Transthyretin Amyloidosis Treatment Product
Table 64. Alnylam Pharmaceuticals, Inc. Revenue in Transthyretin Amyloidosis Treatment Business (2018-2023) & (US$ Million)
Table 65. Alnylam Pharmaceuticals, Inc. Recent Development
Table 66. BridgeBio Pharma, Inc. Company Detail
Table 67. BridgeBio Pharma, Inc. Business Overview
Table 68. BridgeBio Pharma, Inc. Transthyretin Amyloidosis Treatment Product
Table 69. BridgeBio Pharma, Inc. Revenue in Transthyretin Amyloidosis Treatment Business (2018-2023) & (US$ Million)
Table 70. BridgeBio Pharma, Inc. Recent Development
Table 71. Bristol-Myers Squibb Company Company Detail
Table 72. Bristol-Myers Squibb Company Business Overview
Table 73. Bristol-Myers Squibb Company Transthyretin Amyloidosis Treatment Product
Table 74. Bristol-Myers Squibb Company Revenue in Transthyretin Amyloidosis Treatment Business (2018-2023) & (US$ Million)
Table 75. Bristol-Myers Squibb Company Recent Development
Table 76. Acrotech Biopharma Company Detail
Table 77. Acrotech Biopharma Business Overview
Table 78. Acrotech Biopharma Transthyretin Amyloidosis Treatment Product
Table 79. Acrotech Biopharma Revenue in Transthyretin Amyloidosis Treatment Business (2018-2023) & (US$ Million)
Table 80. Acrotech Biopharma Recent Development
Table 81. AstraZeneca Company Detail
Table 82. AstraZeneca Business Overview
Table 83. AstraZeneca Transthyretin Amyloidosis Treatment Product
Table 84. AstraZeneca Revenue in Transthyretin Amyloidosis Treatment Business (2018-2023) & (US$ Million)
Table 85. AstraZeneca Recent Development
Table 86. Astellas Pharma, Inc. Company Detail
Table 87. Astellas Pharma, Inc. Business Overview
Table 88. Astellas Pharma, Inc. Transthyretin Amyloidosis Treatment Product
Table 89. Astellas Pharma, Inc. Revenue in Transthyretin Amyloidosis Treatment Business (2018-2023) & (US$ Million)
Table 90. Astellas Pharma, Inc. Recent Development
Table 91. Prothena Company Detail
Table 92. Prothena Business Overview
Table 93. Prothena Transthyretin Amyloidosis Treatment Product
Table 94. Prothena Revenue in Transthyretin Amyloidosis Treatment Business (2018-2023) & (US$ Million)
Table 95. Prothena Recent Development
Table 96. SOM Biotech Company Detail
Table 97. SOM Biotech Business Overview
Table 98. SOM Biotech Transthyretin Amyloidosis Treatment Product
Table 99. SOM Biotech Revenue in Transthyretin Amyloidosis Treatment Business (2018-2023) & (US$ Million)
Table 100. SOM Biotech Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Transthyretin Amyloidosis Treatment Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Transthyretin Amyloidosis Treatment Market Share by Type: 2022 VS 2033
Figure 3. ATTR-PN Features
Figure 4. ATTR-CM Features
Figure 5. Global Transthyretin Amyloidosis Treatment Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Transthyretin Amyloidosis Treatment Market Share by Application: 2022 VS 2033
Figure 7. Hospital Pharmacies Case Studies
Figure 8. Specialty Pharmacies Case Studies
Figure 9. Retail Pharmacies Case Studies
Figure 10. Online Pharmacies Case Studies
Figure 11. Transthyretin Amyloidosis Treatment Report Years Considered
Figure 12. Global Transthyretin Amyloidosis Treatment Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Transthyretin Amyloidosis Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Transthyretin Amyloidosis Treatment Market Share by Region: 2022 VS 2033
Figure 15. Global Transthyretin Amyloidosis Treatment Market Share by Players in 2022
Figure 16. Global Top Transthyretin Amyloidosis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transthyretin Amyloidosis Treatment as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Transthyretin Amyloidosis Treatment Revenue in 2022
Figure 18. North America Transthyretin Amyloidosis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Transthyretin Amyloidosis Treatment Market Share by Country (2018-2033)
Figure 20. United States Transthyretin Amyloidosis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Canada Transthyretin Amyloidosis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Transthyretin Amyloidosis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Transthyretin Amyloidosis Treatment Market Share by Country (2018-2033)
Figure 24. Germany Transthyretin Amyloidosis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. France Transthyretin Amyloidosis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. U.K. Transthyretin Amyloidosis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Italy Transthyretin Amyloidosis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Russia Transthyretin Amyloidosis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Nordic Countries Transthyretin Amyloidosis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Transthyretin Amyloidosis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Transthyretin Amyloidosis Treatment Market Share by Region (2018-2033)
Figure 32. China Transthyretin Amyloidosis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Japan Transthyretin Amyloidosis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. South Korea Transthyretin Amyloidosis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Southeast Asia Transthyretin Amyloidosis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. India Transthyretin Amyloidosis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Australia Transthyretin Amyloidosis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Transthyretin Amyloidosis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Transthyretin Amyloidosis Treatment Market Share by Country (2018-2033)
Figure 40. Mexico Transthyretin Amyloidosis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Brazil Transthyretin Amyloidosis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Transthyretin Amyloidosis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Transthyretin Amyloidosis Treatment Market Share by Country (2018-2033)
Figure 44. Turkey Transthyretin Amyloidosis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Saudi Arabia Transthyretin Amyloidosis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Pfizer Inc. Revenue Growth Rate in Transthyretin Amyloidosis Treatment Business (2018-2023)
Figure 47. Johnson & Johnson Services, Inc. Revenue Growth Rate in Transthyretin Amyloidosis Treatment Business (2018-2023)
Figure 48. Ionis Pharmaceuticals, Inc. Revenue Growth Rate in Transthyretin Amyloidosis Treatment Business (2018-2023)
Figure 49. Alnylam Pharmaceuticals, Inc. Revenue Growth Rate in Transthyretin Amyloidosis Treatment Business (2018-2023)
Figure 50. BridgeBio Pharma, Inc. Revenue Growth Rate in Transthyretin Amyloidosis Treatment Business (2018-2023)
Figure 51. Bristol-Myers Squibb Company Revenue Growth Rate in Transthyretin Amyloidosis Treatment Business (2018-2023)
Figure 52. Acrotech Biopharma Revenue Growth Rate in Transthyretin Amyloidosis Treatment Business (2018-2023)
Figure 53. AstraZeneca Revenue Growth Rate in Transthyretin Amyloidosis Treatment Business (2018-2023)
Figure 54. Astellas Pharma, Inc. Revenue Growth Rate in Transthyretin Amyloidosis Treatment Business (2018-2023)
Figure 55. Prothena Revenue Growth Rate in Transthyretin Amyloidosis Treatment Business (2018-2023)
Figure 56. SOM Biotech Revenue Growth Rate in Transthyretin Amyloidosis Treatment Business (2018-2023)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed